Handelsavisen
prelaunch
Companies Healthcare 8622.HK
86
8622.HK HKEX Medical Equipment, Supplies & Distribution

8622.Hk

HK$0,21
Open in Charts → Attach watcher ⌖
HKD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
-16,9 %
ROE
-9,8 %
Net margin
-17,7 %
Debt / equity
0,10
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Business. The company operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-9,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 8622.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 8622.HK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the medical equipment, supplies, and distribution industry, providing healthcare services and equipment to customers in the healthcare sector.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure shows a debt-to-equity ratio of 0.1, indicating a relatively low level of leverage. However, the company has a negative net income of -5,006,000 CNY and an operating loss of -4,767,000 CNY, which suggests financial distress. The current ratio of 3.88 indicates strong short-term liquidity, but the negative net cash position after subtracting total debt raises concerns about long-term liquidity.

    In terms of profitability, the company's return on equity is -9.79% and return on assets is -7.52%, both significantly below industry norms. The gross profit margin is 62.83% (17,769,000 / 28,282,000), but the operating and net losses indicate that the company is not converting this gross profit into sustainable earnings. These metrics suggest the company is underperforming relative to its industry peers.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases the risk of revenue volatility due to market-specific factors. The absence of segment or geographic breakdown in the financial data limits the ability to assess the company's exposure to different markets.

    The company's growth trajectory is uncertain, with no disclosed revenue growth rates or future projections. The negative operating and net income suggest a declining performance, and without clear evidence of turnaround strategies or market expansion, the company's future growth prospects appear limited.

    The company faces significant financial risks, including a negative net income and operating loss. The liquidity risk is medium, and the dilution risk is low, but the negative net cash position after subtracting total debt is a key flag. The company may need to raise additional capital or restructure its debt to address these financial challenges.

    Recent events and filings have not been disclosed in the available data, so there is no information on recent strategic moves, management changes, or regulatory actions that could impact the company's performance. The lack of recent event data limits the ability to assess the company's current strategic direction.

    Key takeaways
    • The company is experiencing significant financial distress with negative operating and net income.
    • The company has a strong current ratio but a negative net cash position after subtracting total debt.
    • The company's return on equity and return on assets are significantly below industry norms.
    • The company's revenue is concentrated in a single business segment with no geographic diversification.
    • The company's growth trajectory is uncertain, and there is no evidence of turnaround strategies or market expansion.
    • "margin_outlook_rationale": "The company's gross profit margin is 62.83%, but the negative operating and net income suggest declining profitability.",

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    HK$0,21
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    HK$51.1M
    Net cash
    -HK$5.0M
    Current ratio
    3.9
    Debt / equity
    0.1
    ROA
    -7.5%
    ROE
    -9.8%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-16,9 %Below median
    Net Margin-17,7 %Below median
    ROE-9,8 %Bottom quartile
    D/E0,10Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Assets
      net_income / total_assets
    Source documents
    • 8622.HK Market data — financials · 2026-05-27

    Ownership & reference

    Leadership

    • Chunguang ZhangChief Executive Officer, Executive Director
    • Shuguang ZhangExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    8622.HKCanonical
    HKEX · HKD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage